U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
155071155071Heart Failure RegistryCompletedNo Results AvailableHeart Failure, Congestivehttps://ClinicalTrials.gov/show/NCT00530426
155072155072Study of Phenobarbital Inhibition of Catamenial EpilepsyWithdrawnNo Results AvailableEpilepsyDrug: Phenobarbital|Other: Placebohttps://ClinicalTrials.gov/show/NCT00530413
155073155073Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk SurgeryCompletedNo Results AvailableSurgical Wound InfectionDrug: cefuroxime|Drug: placebohttps://ClinicalTrials.gov/show/NCT00530400
155074155074Multi-Centre European Photopatch Test StudyCompletedNo Results AvailableDermatitis, PhotocontactDrug: 19 organic sunscreen filters and 5 topical NSAIDshttps://ClinicalTrials.gov/show/NCT00530387
155075155075Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly PrevalentCompletedNo Results AvailableMalnutrition|Iron DeficiencyDietary Supplement: Oral Iron Supplement|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00530374
155076155076An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)WithdrawnNo Results AvailableCoronary Artery Bypass Surgery|Coronary Heart Disease|Coronary Artery Bypass Grafting|Cardiopulmonary Bypass|Ischemic Heart Disease|Heart Failure, CongestiveDrug: Nesiritidehttps://ClinicalTrials.gov/show/NCT00530361
155077155077Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study OneCompletedHas ResultsMultiple Sclerosis, Relapsing-RemittingBiological: Alemtuzumab|Biological: Interferon beta-1ahttps://ClinicalTrials.gov/show/NCT00530348
155078155078Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedHas ResultsAttention Deficit Hyperactivity DisorderDrug: Atomoxetinehttps://ClinicalTrials.gov/show/NCT00530335
155079155079Adhesion Formation Following Laparoscopic and Open Colorectal SurgeryCompletedNo Results AvailableAdhesionsProcedure: Laparoscopyhttps://ClinicalTrials.gov/show/NCT00530322
155080155080Clinical Assessment of GSK716155 for Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes Mellitus|Diabetes Mellitus, Type 2Drug: GSK716155 for injectionhttps://ClinicalTrials.gov/show/NCT00530309
155081155081CBT to Treat Depression in Renal PatientsRecruitingNo Results AvailableDepression|End Stage Renal DiseaseBehavioral: Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT00530296
155082155082PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary MalignancyCompletedNo Results AvailableSquamous Cell CancerOther: PET-CThttps://ClinicalTrials.gov/show/NCT00530283
155083155083Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell DiseaseTerminatedHas ResultsAnemia, Sickle CellDrug: Dexamethasone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00530270
155084155084Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and MemoryCompletedHas ResultsAttention Deficit Hyperactivity DisorderDrug: Placebo|Drug: OROS-methylphenidatehttps://ClinicalTrials.gov/show/NCT00530257
155085155085Use of Formula Fortified With DHA in Infants With Cystic FibrosisCompletedNo Results AvailableCystic FibrosisDietary Supplement: Docosahexaenoic acid (DHA)|Dietary Supplement: Standard formula (Enfamil)https://ClinicalTrials.gov/show/NCT00530244
155086155086Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule EndoscopyRecruitingNo Results AvailableCapsule Endoscopyhttps://ClinicalTrials.gov/show/NCT00530231
155087155087Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow TransplantCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative DiseasesDrug: ganciclovir|Other: pharmacological study|Procedure: allogeneic hematopoietic stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00530218
155088155088Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung CancerWithdrawnNo Results AvailableLung Cancer|Malnutrition|Weight ChangesOther: physiologic testing|Other: questionnaire administration|Procedure: management of therapy complications|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00530205
155089155089Molecular Profiling Protocol (SCRI-CA-001)CompletedNo Results AvailableRefractory CancerOther: Treatment based on Molecular Profilinghttps://ClinicalTrials.gov/show/NCT00530192
155090155090FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell LymphomaActive, not recruitingNo Results AvailableDiffuse Large B Cell LymphomaProcedure: Autologous Blood Stem Transplantation|Drug: R-CHOP (Rituximab, Cyclphosphamide, Etoposide, Cisplatin, Mesna, G-CSFhttps://ClinicalTrials.gov/show/NCT00530179
155091155091Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.TerminatedNo Results AvailableAsthmaDrug: JNJ-18054478|Drug: sham comparatorhttps://ClinicalTrials.gov/show/NCT00530166
155092155092School Intervention Study of Nutrition, Wellbeing and Dental HealthActive, not recruitingNo Results AvailableEating|Oral HealthBehavioral: dietary counseling|Dietary Supplement: xylitolhttps://ClinicalTrials.gov/show/NCT00530153
155093155093Idiotypic Vaccination for Follicular Lymphoma PatientsRecruitingNo Results AvailableFollicular Lymphoma|First Relapse/ProgressionBiological: Follicular lymphoma, patient-specific, soluble protein idiotype vaccinehttps://ClinicalTrials.gov/show/NCT00530140
155094155094A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's AtaxiaCompletedNo Results AvailableFriedreich's AtaxiaDrug: placebo|Drug: deferiprone|Drug: deferiprone|Drug: placebo|Drug: deferipronehttps://ClinicalTrials.gov/show/NCT00530127
155095155095Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With HyperphosphatemiaCompletedNo Results AvailableEnd Stage Renal Disease|Chronic Kidney Disease|Hyperphosphatemic|Kidney DiseaseDrug: AMG 223|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00530114
155096155096The Magnetic Resonance Imaging Evaluation of Doxorubicin CardiotoxicityCompletedNo Results AvailableBreast CancerDrug: Doxorubicinhttps://ClinicalTrials.gov/show/NCT00530101
155097155097Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or ThroatTerminatedHas ResultsHead and Neck CancerDrug: porfimer sodium|Drug: Photdynamic Therapy (PDT)https://ClinicalTrials.gov/show/NCT00530088
155098155098Phase II Study on Gusperimus in Patients With Refractory Wegener's GranulomatosisCompletedNo Results AvailableWegener's GranulomatosisDrug: Gusperimushttps://ClinicalTrials.gov/show/NCT00530075
155099155099Comparison of Single-Dose Efficacy of an Albuterol Breath Activated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered Dose Inhaler (HFA-MDI) (Both Using the Same Hydrofluoroalkane Propellant) in AsthmaticsCompletedNo Results AvailableAsthmaDrug: Albuterol-HFA-MDI|Drug: Albuterol-HFA-BAIhttps://ClinicalTrials.gov/show/NCT00530062
155100155100Measuring Patient Satisfaction With Facial Appearance: Development and Validation of a New Patient-Reported Outcome MeasureActive, not recruitingNo Results AvailableHead and Neck Cancer|Psychosocial Effects of Cancer and Its TreatmentOther: questionnaire administration|Procedure: assessment of therapy complications|Procedure: psychosocial assessment and care|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00530049

* Görseller ve İçerik tekif hakkına sahip olabilir